Key Takeaways
- • Development Partners International (DPI) has closed a $190 million minority stake investment in Alameda Healthcare, Egypt's leading private healthcare group, marking the largest healthcare investment of its kind in Egypt to date.
- • The capital raise will fund Alameda's expansion across Egypt and into Gulf Cooperation Council (GCC) markets, including investments in advanced medical technologies and scaling of Centers of Excellence.
- • Dr. Fahad Khater remains Alameda's majority shareholder and Chairman, with DPI and co-investors providing strategic expertise and operational support alongside their equity commitment.
- • This investment positions DPI as a major deployer of capital in Egypt's healthcare sector as part of its broader Africa-focused strategy managing over $3 billion in assets and co-investments.
- • The transaction, signed in July 2025, was expected to close in Q3 2025, subject to regulatory approvals, amid Egypt's broader private sector investment target of $42 billion for fiscal year 2026-2027.
Summary
Development Partners International has completed a $190 million minority stake investment in Alameda Healthcare, Egypt's leading private healthcare operator with over 1,000 beds since its establishment in 1999. The transaction, announced in July 2025 and structured primarily as a capital increase, represents the largest healthcare investment of its kind in Egypt and underscores DPI's commitment to deepening its presence in the Egyptian market as part of its Africa-focused investment strategy.
The investment will accelerate Alameda's geographic and operational expansion both within Egypt and across Gulf Cooperation Council markets. Proceeds will be deployed toward broadening Alameda's physical footprint and bed capacity, acquiring advanced medical technologies, and scaling the Group's Centers of Excellence—facilities designed to provide specialized care and establish regional competitiveness. This capital infusion addresses the Group's growth ambitions in a healthcare sector increasingly attractive to institutional investors seeking exposure to emerging-market demographic trends and rising healthcare consumption.
DPI's investment structure preserves founder control, with Dr. Fahad Khater retaining his position as majority shareholder and Chairman while collaborating with DPI's investment and operational teams. This governance approach reflects a common practice in emerging-market healthcare deals where founder expertise and market relationships remain critical to execution. As an Africa-focused private equity firm managing over $3 billion in assets and co-investments, DPI's involvement signals confidence in Alameda's management, market position, and regional expansion potential.
The timing of this deal aligns with Egypt's broader macroeconomic context. The Egyptian government is targeting nearly $42 billion in private sector investment during fiscal year 2026-2027, creating a favorable environment for large-scale institutional capital deployment. DPI's healthcare investment complements its portfolio diversification strategy in Egypt, which has included retail-focused investments such as its $50 million commitment to Egyptian retailer Kazyon for expansion into Morocco, demonstrating a multi-sector approach to regional growth.
The investment will accelerate Alameda's geographic and operational expansion both within Egypt and across Gulf Cooperation Council markets. Proceeds will be deployed toward broadening Alameda's physical footprint and bed capacity, acquiring advanced medical technologies, and scaling the Group's Centers of Excellence—facilities designed to provide specialized care and establish regional competitiveness. This capital infusion addresses the Group's growth ambitions in a healthcare sector increasingly attractive to institutional investors seeking exposure to emerging-market demographic trends and rising healthcare consumption.
DPI's investment structure preserves founder control, with Dr. Fahad Khater retaining his position as majority shareholder and Chairman while collaborating with DPI's investment and operational teams. This governance approach reflects a common practice in emerging-market healthcare deals where founder expertise and market relationships remain critical to execution. As an Africa-focused private equity firm managing over $3 billion in assets and co-investments, DPI's involvement signals confidence in Alameda's management, market position, and regional expansion potential.
The timing of this deal aligns with Egypt's broader macroeconomic context. The Egyptian government is targeting nearly $42 billion in private sector investment during fiscal year 2026-2027, creating a favorable environment for large-scale institutional capital deployment. DPI's healthcare investment complements its portfolio diversification strategy in Egypt, which has included retail-focused investments such as its $50 million commitment to Egyptian retailer Kazyon for expansion into Morocco, demonstrating a multi-sector approach to regional growth.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.